Transmucosal drug delivery devices are used to deliver drugs through the mucous membranes of the mouth, nose, or rectum. Transmucosal drug delivery devices are used for a variety of applications including hospital and residential settings. The global transmucosal drug delivery devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2021-2030. The global transmucosal drug delivery devices market is segmented by type, application and region. The type segment includes buccal route, nasal route and rectal route. The application segment includes hospital and residential settings. The region segment includes North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions respectively.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and asthma is driving the growth of the Transmucosal Drug Delivery Devices market.
- Increasing demand for self-administration of drugs by patients is also driving the growth of the Transmucosal Drug Delivery Devices market.
- The increasing number of new product launches in this segment are also driving the growth of this market.
- The increasing use of these devices in hospitals and clinics for administration purposes is also contributing to the growth.
Industry Growth Insights published a new data on “Transmucosal Drug Delivery Devices Market”. The research report is titled “Transmucosal Drug Delivery Devices Market research by Types (Buccal Route, Rectal Route, Nasal Route), By Applications (Hospital, Residential), By Players/Companies Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, Callitas Therapeutics Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transmucosal Drug Delivery Devices Market Research Report
By Type
Buccal Route, Rectal Route, Nasal Route
By Application
Hospital, Residential
By Companies
Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, Callitas Therapeutics Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Transmucosal Drug Delivery Devices Market Report Segments:
The global Transmucosal Drug Delivery Devices market is segmented on the basis of:
Types
Buccal Route, Rectal Route, Nasal Route
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Residential
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Amphastar Pharmaceuticals Inc
- Aquestive Therapeutics Inc
- ARS Pharmaceuticals
- Combinent BioMedical Systems Inc
- Aegis Therapeutics LLC
- Bespak Europe Ltd
- Callitas Therapeutics Inc
Highlights of The Transmucosal Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Buccal Route
- Rectal Route
- Nasal Route
- By Application:
- Hospital
- Residential
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transmucosal Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transmucosal drug delivery devices (TDDs) are a type of medical device that is inserted into the mouth to deliver medications directly to the stomach and small intestine.
Some of the major players in the transmucosal drug delivery devices market are Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, Callitas Therapeutics Inc.
The transmucosal drug delivery devices market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transmucosal Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transmucosal Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transmucosal Drug Delivery Devices Market - Supply Chain
4.5. Global Transmucosal Drug Delivery Devices Market Forecast
4.5.1. Transmucosal Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transmucosal Drug Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transmucosal Drug Delivery Devices Market Absolute $ Opportunity
5. Global Transmucosal Drug Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Buccal Route
5.3.2. Rectal Route
5.3.3. Nasal Route
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transmucosal Drug Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Residential
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transmucosal Drug Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transmucosal Drug Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transmucosal Drug Delivery Devices Demand Share Forecast, 2019-2026
9. North America Transmucosal Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Residential
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Buccal Route
9.7.2. Rectal Route
9.7.3. Nasal Route
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transmucosal Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Transmucosal Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Residential
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Buccal Route
10.7.2. Rectal Route
10.7.3. Nasal Route
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transmucosal Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Transmucosal Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Residential
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Buccal Route
11.7.2. Rectal Route
11.7.3. Nasal Route
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transmucosal Drug Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Transmucosal Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Residential
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Buccal Route
12.7.2. Rectal Route
12.7.3. Nasal Route
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transmucosal Drug Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Transmucosal Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Residential
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transmucosal Drug Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Buccal Route
13.7.2. Rectal Route
13.7.3. Nasal Route
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transmucosal Drug Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transmucosal Drug Delivery Devices Market: Market Share Analysis
14.2. Transmucosal Drug Delivery Devices Distributors and Customers
14.3. Transmucosal Drug Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amphastar Pharmaceuticals Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aquestive Therapeutics Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ARS Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Combinent BioMedical Systems Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aegis Therapeutics LLC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bespak Europe Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Callitas Therapeutics Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook